The prevalence of metabolic disorders, obesity and insulin resistance in women with polycystic ovary syndrome are present starting early in life, and places this group in the risk of cardiovascular disease. Hyperhomocysteinemia and increased CRP activity have an effect on promoting atherosclerosis. This study was designed to evaluate whether hs-CRP 
Introduction
One of the most frequent conditions frequently seen in women of reproductive age is polycystic ovary syndrome (PCOS). This condition affects 12-19 % of the female population and this usually depends on ethnicity and criteria used for diagnosing PCOS (1), (2) . Diagnosis for PCOS is defined by the Rotterdam classification from 2003 where at least 2 out of 3 criteria must be present: oligo and/or anovulation, clinical and/or biochemical hyperandrogenism and polycystic ovaries on ultrasound (3) . This heterogeneous endocrine disorder is presented by different clinical sub-phenotypes and the phenotype prevalence generally depends whether it is diagnosed in the tertiary health care setting or detected randomly in an unselected population. This may be due to several reasons like race/ethnicity predominance, severity of clinical manifestation, access to medical care, degree of obesity and the severity of hirsutism, which are the complaints most likely to affect quality of life and reason to seek medical assistance (4) . Apart from the well-known characteristics of polycystic ovary syndrome, these women are facing many other endocrine disturbances including fertility problems, insulin resistance (IR), impaired glucose tolerance, hyperinsulinemia, dyslipidemia and assemblage of metabolic syndrome profile. Data has shown an increased diabetes risk, hypertension all of which are cardiovascular risk factors (5), (6) . These risks can be aggravated by PCOS management strategies and by presence of high BMI. Some important therapies, like the oral contraceptive pill (OCP) affecting the reproductive features such as menstrual cycle regulation and hirsutism management, may also increase cardiovascular risk (7), (8) .
Obesity and excess weight are major chronic diseases in Western world countries. In general, population, obesity and insulin resistance increases type 2 diabetes (T2DM) and cardiovascular disease (CVD). Similarly, in PCOS obesity stimulates insulin resistance and promotes reproductive and metabolic disarrangements (9) . Metabolic features, combined with excess weight often seen in PCOS, make these young women a high-risk group.
Chronic inflammation may be one of the factors contributing to obesity and obesity-related disorders, including atherosclerosis and endothelial dysfunction, diabetes, and steatosis (10) . These changes are present at adipose tissue level but also liver, muscles, macrophages usually because of altered homeostasis of inflammatory cytokines. Adipose tissue a potent endocrine organ which synthetized and releases cytokines, acute-phase proteins, and inflammatory mediators. These molecules have paracrine, autocrine or systemic function influencing glucose metabolism, energy balance, proinflammatory and anti-inflammatory activities (11) . Serum markers of low-grade chronic inflammation are being increasingly recognised as predictors of cardiovascular disease over the past years. Homocysteine (Hcy), a thiol-containing amino acid, is produced by the intracellular demethylation of methionine. Total homocysteine (tHcy) represents the sum of all forms of Hcy including oxidised, protein-bound and free Hcy. Accumulation of Hcy is usually is seen as a result of the defect in enzymatic pathway (12) . Several studies indicate that non-enzymatic factors also can influence Hcy levels-including age, gender, nutrition, smoking (13) . Wald et al. have found significant associations between homocysteine concentration and the risk of ischemic heart disease, deep vein thrombosis. According to the authors, the results of the meta-analysis provide strong evidence for a causal relationship between elevated blood homocysteine and cardiovascular disease (14) . Hs-CRP is an acute phase protein produced by the liver, directly secreted by adipose tissue or but also there have been suggestions that it is produced in the atherosclerotic lesion, smooth muscle cells and macrophages (15) .
There has been increased interest of use of homocysteine and hs-CRP as early markers for early subclinical inflammation and atherosclerosis to improve risk stratification in asymptomatic individuals (13) , (15) .
The present study aimed to evaluate the relationships of plasma Hcy and hs-CRP levels with anthropometric and biochemical parameters and their correlation with metabolic profile of women with PCOS.
Methods
A cross-sectional study was conducted at the department of Clinical Chemistry, University Clinic for Gynecology and Obstetrics, Republic of Macedonia. The study and all procedures were approved by the ethical committee for research on people and animals, at the Medical Faculty in Skopje, University St." Cyril and Methodius", Macedonia. All participants in the study signed informed consent before its participation in the study Seventy-three premenopausal, 18 to 40-year old women with polycystic ovary syndrome based on the diagnostic criteria from the Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group were involved in this study (3) . The control group consisted of 43 age-matched healthy females who volunteered for this study. All participants completed a questionnaire that includes age, marital status, lifestyle habits, and use of vitamin supplementation. Participants' anthropometric assessment including body weight, height, waist and hip circumference were assessed. Patients with abnormal levels of prolactin, thyroid hormones, renal or hepatic dysfunction, and diabetes type 1 or 2, congenital adrenal hyperplasia were excluded. Patients using any medication like hormonal supplementation and insulin sensitizers or any vitamins in a period of 6 months were excluded.
Biochemical measurements.
All blood samples were taken from subjects after 12-14 hours overnight fasting between 3- 
Statistical analysis
All statistical procedures were done using SPSS 17 software for Windows. KolmogorovSmirnov test was performed for the normality of distribution of all variables. Data were expressed as a mean ± standard deviation. Comparisons between groups are performed using the independent t-test. Correlation analyses between Hcy and hs-CRP and other variables was obtained using Spearman rank coefficient. Differences between groups were considered to be statisticaly significant for the p ≤ 0.05.
Results
From 116 included women, 73 were with PCOS and 43 were a healthy woman. All participants were Caucasian, represented of nationalities that live on the territory of R.
Macedonia. Anthropometric and hormonal characteristics of a woman with PCOS and control group are summarised in Table 1 .
There was no statistical differences between the mean age of two groups of a woman 
Discussion
Our study results demonstrated that patients with PCOS have increased inflammatory markers compared to age and BMI-matched control group indicating that the inflammation seen in PCOS might be related with the presence of disorder rather than obesity PCOS is a proinflammatory disorder and increased levels of circulatory inflammatory markers such as TNF -alpha, IL-have been found in several studies (10), (16) . The reasons of presence of low level chronic inflammation in PCOS has not been clarified yet, and it remains uncertain whether it is connected with PCOS itself or the associated with obesity.
It has been shown that both obesity and inflammation contribute to the metabolic complications for women of reproductive age. The state of the cardiovascular system in women with PCOS might be due to different factors, including insulin resistance, androgen status and BMI (6) . However, excess androgen should be the most important component of
PCOS (17).
Women with polycystic ovarian syndrome face a variety of metabolic disorders, among which dysfunction of insulin activity has the most significant effect on the disorders presented later in life. Obesity, hyperinsulinemia, hyperandrogenaemia, insulin resistance are some of the metabolic disorders which shadow this syndrome and rising the question of possible increased cardiovascular risk among these women. High-sensitivity CRP is an acute phase protein that is mainly produced by the liver as a response to multiple reasons mainly increased levels of systemic inflammatory cytokines -tumor necrosis factor-α WHR. This finding suggests the increased risk of early atherosclerosis and cardiovascular events in PCOS women, which at the same time is more pronounced and dependent of accumulated central fat deposit. In a study with a Croatian cohort of PCOS woman, with a low prevalence of obesity, was found a significant association between SHBG and CRP, independent of insulin resistance measured by HOMA-IR, supporting that low SHBG concentrations can be independent marker of enhanced cardiovascular risk in females with PCOS (27) . In our study we have observed significant strong negative correlation between hs-CRP and SHGB, and weak positive correlation with FAI. We did not find any correlation with androgen levels. However, hs-CRP levels correlated with LH and LH/FSH ratio, triglycerides and LDL-C. This emphasises that obesity and metabolic alterations have influence in low-grade chronic inflammation and elevated CRP in PCOS woman.
Moderately increased Hcy has a cytotoxic effect on vascular endothelium where oxidative stress leads to endothelial dysfunction and causing vascular remodelling (28) . vitamins and folic acid (33) . The strong side of this study was that all involved subject were non-smokers, no vegetarians, and none of them was using any vitamin supplements, so the factor that can influence homocysteine concentrations were eliminated.
Conclusion
The results of this study demonstrated presence of low-grade chronic inflammation and increased inflammatory markers among Macedonian adolescent woman with PCOS compared to the corresponding BMI-matched control group. There is a growing data of evidence indicating disturbed homocysteine metabolism, as well as confirmation for presence of chronic inflammation in PCOS women, leading to increased CVR risk. Screening for hyperhomocysteinemia can be valuable before the use of oral contraceptive pills at a young age. Lifestyle changes with diet and exercise interventions particularly in overweight category can be advised in terms of limiting factors who are associated with increased cardiovascular risk, insulin resistance, hypertension, and dyslipidemia.
